肝硬化并发自发性细菌性腹膜炎患者腹水病原菌鉴定及耐药性分析

doi:10.3969/j.issn.1672-5069.2014.02.021

Abstract

Wang Jun，Peng Hao.. Ascitic spectrum of pathogens and drug tolerance in cirrhotic patients with spontaneous bacterial peritonitis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 190-191.

[1] 占国清，谭华炳，李芳，等. 肝硬化发生自发性细菌性腹膜炎的危险因素分析. 实用肝脏病杂志，2011，14（5）:349-350.
[2] 李儒贵，谭华炳，占国清，等. 肝硬化合并自发性细菌性腹膜炎预后影响因素分析. 临床肝胆病杂志，2011，27（2）:170-173.
[3] 李显勇，夏刚. 自发性腹膜炎对慢性肝衰竭预后的影响.实用肝脏病杂志，2010，13（5）:375-376.
[4] 韩亚芳，陈佐云，赵涛，等. 肝硬化合并自发性细菌性腹膜炎的病原菌耐药性调查. 中华医院感染学杂志，2011，21（15）:3292-3293.
[5] 黄培宁，邓有辉，余贤恩，等. 肝硬化并发腹膜炎的影响危险因素及预后因素分析. 现代预防医学，2011，38（19）:4027-4028.
[6] 王建忠，费迎明，金法祥. 肝硬化并发自发性腹膜炎腹水中大肠埃希菌耐药性和基因型分布的研究.中华医院感染学杂志，2010，20（4）:466-468.
[7] 李智，周全胜，樊和斌，等. 肝硬化并发自发性腹膜炎腹水病原菌及药物敏感性分析. 现代中西医结合杂志，2011，20（3）:289-290.
[8] 杨玉贵.肝硬化自发性腹膜炎腹水的病原菌及耐药性探讨.中国当代医药，2013，20（2）:195-196.
[9] 王建忠.肝硬化并发自发性腹膜炎腹水培养的病原菌及大肠埃希菌的耐药性分析. 中国卫生检验杂志，2009，19（1）:139-140.
[10] 张文瑾，范振平.肝硬化患者合并自发性细菌性腹膜炎的防治.中国临床医学，2011，18（5）:569-570.
[11] 刘淼，王洪. 肝硬化并发自发性腹膜炎患者腹水培养的病原菌及耐药性分析. 中国冶金工业医学杂志，2013，30（2）:190.
[12] 董志超. 肝硬化并发自发性腹膜炎腹水培养的病原菌及其耐药性分析. 中国实用医药，2011，6（18）:187-188.
[13] 苗文才. 肝硬化并自发性腹膜炎腹水培养的病原菌及耐药性探讨. 临床医学，2012，32（3）:53-54.
[14] 尹琳. 肝硬化并发自发性腹膜炎腹水培养的病原菌及耐药性评价. 中国实用医药，2011，6（18）:145-146.
[15] 张艳梅，陈一晖，戴虹. 肝硬化并发自发性腹膜炎病原菌及药敏分析. 中国医药导报，2010，7（33）:107-108.

Ascitic spectrum of pathogens and drug tolerance in cirrhotic patients with spontaneous bacterial peritonitis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Cui Ruibing, Yan Ming.. Etiology of ascites:what’s going on [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 657-660.
[2]	Liang Jing, Han Tao.. Highlights of diagnosis and evaluation of ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 661-664.
[3]	Li Yue, Ding Huiguo.. Current diagnosis and treatment of chylous ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 665-668.
[4]	Wu Wenhao, Fu Hanguang, Chen Zhaoqin. Clinical features,pathogenic distribution and drug susceptibility in patients with liver cirrhosis complicated by spontaneous bacterial peritonitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 356-359.
[5]	Liu Honghong, Zhao Ping. Insight of diagnosis and treatment of ascites in cirrhotics with integrated traditional Chinese and western medicine [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 485-488.
[6]	. Guidelines on the management of ascites and complications in cirrhosis Chinese Society of Hepatology, Chinese Medical Association [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 21-31.
[7]	Ma Li, Department of Gastroenterology, JianLi433300, JingZhou, HuBei Province;Yu Chuanke, Li Peixia, Wei Yaoling, et al.. Albumin transfusion and continunous paracentesis versus branched chain amino acids with diuretics in treatment of patients liver cirrhosis and tension ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 496-497.
[8]	Liu Yuling, Feng Zhenqing, Jia Qiulong, et al.. Changes of serum liver fibrosis index in patients with hepatitis B-induced liver cirrhosis complicated by spontaneous bacterial peritonitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 356-357.
[9]	Zhao Yanan， Cao Shanshan，Li Hong.. Clinical serological parameters in patients with alcoholic cirrhosis with or without ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 183-186.
[10]	Cheng Ya，Qiao Xiaofei，Jia Weidong.. Therapeutic effects of terlipressin in treatment of patients with decompensated cirrhosis resulting from chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 687-691.
[11]	Ju Chaoxia, Chen Judi, Zhou Meifang, et al. Peritoneal intubation lavage in cirrhotic patients with spontaneous bacterial peritonitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 482-483.
[12]	Zhu Junfeng, Qian Ping'an, Fan Xingliang. Efficacy of XiaoShuiFang and tolvaptan in the treatment of patients with hepatitis B-induced liver cirrhosis complicated by refractory ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 192-195.
[13]	Xiao Li，Yang Ling. Application of vasoconstrictors in management of patients with refractory ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 460-462.
[14]	Tong Fangfang. TNF alpha, IL-6 and IL-8 levels in sera and ascites of patients with iver cirrhosis complicated by spontaneous bacterial peritonitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 191-192.
[15]	Tian Qiuju, Jia Jidong. Focus on emerging concepts for the treatment of patients with liver cirrhosis and refractory ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 1-3.